Overview

A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

Status:
NOT_YET_RECRUITING

Trial end date:
2027-01-21

Target enrollment:

Participant gender:

Summary

The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis

Phase:

PHASE2

Details

Lead Sponsor:

Laboratoires Thea

Treatments:

Cyclosporine
Slit Lamp Microscopy